SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $524,358,409 |
| Positions | 88 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $105,369,346 | 562,630 |
| SPDR S&P BIOTECH ETF | XBI | ETF | $31,096,916 | 196,505 |
| COMPASS PATHWAYS PLC | CMPS | SPONSORED ADS | $28,469,121 | 2,011,952 |
| STEREOTAXIS INC | STXS | COM NEW | $23,530,553 | 13,680,554 |
| NEKTAR THERAPEUTICS | NKTR | COM NEW | $22,226,108 | 318,380 |
| DENALI THERAPEUTICS INC | DNLI | COM | $19,007,440 | 739,014 |
| IDEAYA BIOSCIENCES INC | IDYA | COM | $18,532,135 | 497,240 |
| ATRICURE INC | ATRC | COM | $16,716,119 | 597,431 |
| XENON PHARMACEUTICALS INC | XENE | COM | $15,136,598 | 250,772 |
| CYTOKINETICS INC | CYTK | COM NEW | $14,652,510 | 171,998 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.